Swiss Drug Manufacturers—Specialty & Generic Industry Analysis

Benchmark and data visualization of Swiss public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.

Switzerland public listed companies in the Drug Manufacturers—Specialty & Generic industry: 5

Switzerland Drug Manufacturers—Specialty & Generic total companies market cap (USD): $15.55 Billion

format_list_bulleted List of Swiss Drug Manufacturers—Specialty & Generic Companies
Switzerland Analysis Top Swiss Companies
language World Companies Analysis language World Top Companies
  • filter_listAdvanced Analysis & Companies Filter

    Country / Territory

    AND / OR

    Sector / Industry

    Stock Index

Stock Performance Comparison of the 3 Largest Swiss Drug Manufacturers—Specialty & Generic Companies

file_download

1-year stock performance comparison (base-100 daily closing prices)

show_chart VIFN show_chart SFZN show_chart PPGN

Largest 5 Companies in the Swiss Drug Manufacturers—Specialty & Generic Industry by Market Cap

Top 5 Swiss Drug Manufacturers—Specialty & Generic Industry Companies Details as of Jan. 1, 2023

Company Market Cap (USD) Country Sector Industry
Vifor Pharma AG $11.73 B

(Dec. 1, 2022)

 Switzerland data.Industry.None
Siegfried Holding AG $2.84 B Switzerland data.Industry.None
PolyPeptide Group AG $983.0 M Switzerland data.Industry.None
El.En. SpA $5.1 M Switzerland data.Industry.None
SES Solar, Inc. $None

(Jan. 11, 2021)

 Switzerland data.Industry.None
format_list_bulleted List of Companies: Switzerland Drug Manufacturers—Specialty & Generic